Montana
This data is meant to be used for educational purposes to inform providers, patients, insurers, and state Medicaid agencies what genetic services may or may not be written into each state’s Medicaid policy. The database is not meant to indicate or imply whether a certain program will cover a specific service, since many decisions are made on a case by case basis. If you have specific questions about whether a service is covered, you should reach out to your plan administrator. Please see this disclaimer below for more information.
Medicaid Coverage Information Published
State Contact Information
Adam Meier, Director of Health and Human Services
(406) 444-5623
General Genetic Testing Criteria
- Pre- and post-test genetic counseling must be provided;
- The requested test must be performed by a CLIA-certified laboratory;
- Genetic testing is recommended in place of, to confirm or to rule out, a clinical diagnosis;
- The requested test is not considered experimental or investigational;
- The requested laboratory test is to provide clinical benefit (the course of treatment may change) to the patient;
- Current signs or symptoms, or a family history suggest a genetic condition;
- Current medical records (applicant must have been seen within the last six months) and physician notes verify the confirmed or suspected medical condition for which testing is being planned.
Genetic Testing Not Covered
State Specific Definition
Genetic Services for Children
Genetic testing for Children’s Mental Health is covered. Youth must meet the SED criteria as described in this manual and additional criteria below:
- Youth displays clinical feature or is at direct risk of inheriting a gene that testing is necessary to improve clinical outcomes of neuropsychiatric medication.
- Documented previous medication failures and intent to alter medication course consistent with test results. Youth must have failed or currently be failing on at least one neuropsychiatric medication.
- Results of test will directly impact treatment being delivered to the patient.
- Documentation of risk and clinical need must include a comprehensive history, physical examination and completion of conventional diagnostic studies.
Genetic Counseling Requirement
It is mandatory that a client who is at risk for BRCA1, BRCA2, or BRCA large rearrangement genetic mutation receive genetic counseling before and after BRCA gene mutation testing.
Metabolic Formula Coverage Legislation
Metabolic Formula Coverage & Criteria
Prior Authorization Requirements
Prior Authorization Forms
Fee Schedule
BRCA Testing Coverage
Requirements for BRCA
- Personal history of any of the following:
- Breast cancer diagnosis at or before age 45.
- Breast cancer diagnosis at or before age 50 with any of the following:
- An additional breast cancer primary;
- 1 or more close blood relative with breast cancer at any age;
- 1 or more close blood relative with pancreatic cancer; or
- 1 or more close blood relative with prostate cancer with a Gleason score ≥7.
- 4. Breast cancer diagnosis at or before age 60 with:
- Triple negative breast cancer.
- 5. Breast cancer diagnosis at any age with any of the following:
- 1 or more close relatives with breast cancer diagnosed before age 50;
- 2 or more close blood relatives with breast cancer diagnosis at any age;
- 1 or more close blood relative with ovarian cancer diagnosis;
- 2 or more close blood relatives with pancreatic cancer diagnosis or prostate cancer diagnosis with a Gleason score ≥7;
- 1 or more close blood relative diagnosed with male breast cancer.
- 6. Male breast cancer diagnosis at any age.
- 7. Ovarian cancer diagnosis at any age.
- 8. Fallopian tube cancer diagnosis at any age.
- 9. Primary peritoneal cancer diagnosis at any age.
- 10. Prostate cancer diagnosis with a Gleason score 7 at any age with any of the following:
- 1 or more close blood relative with ovarian cancer at any age;
- 1 or more close blood relative with breast cancer before age 50;
- 2 or more close blood relatives with breast,pancreatic, or prostate cancer (Gleason score ≥7) at any age.
- 11. Pancreatic cancer diagnosis at any age with any of the following:
- aAshkenazi Jewish ancestry;
- 1 or more close blood relative with ovarian cancer at any age;
- 1 or more close blood relative with breast cancer before age SO;
- 2 or more close blood relatives with breast,pancreatic,or prostate cancer (Gleason score ≥7) at any age.
- Family history of any of the following:
- First or second degree blood relative who meet any of the above criteria.
- Third degree blood relative who has breast cancer and/or ovarian cancer and who has 2 or more close blood relatives with breast cancer (at least one with breast cancer before age SO) and/or ovarian cancer.
- 1 or more family member with a known potentially harmful mutation In the BRCAl or BRCA2 gene.
Cystic Fibrosis Screening
Hereditary Cancer Testing Coverage
Coverage is available.
Lynch Syndrome Testing Coverage
Coverage is available.
Microarray Testing
Newborn Screening
Panel Testing
- Amino acid metabolism disorders, including Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria (HCY), Citrullinemia/ Arginosuccinic Acidemia (CIT/ASA) and Tyrosinemia Type I (TYR1).
- Organic acidemia disorders, including 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMG), 3-Methylcrotonyl-CoA carboxylase deficiency (3MCC), β-ketothiolase deficiency (BKT), Glutaric acidemia type I (GA1), Isovaleric acidemia (IVA), Methylmalonic acidemia (MUT and CblA,B), Multiple carboxylase deficiency (MCD), Propionic acidemia (PROP).
- Fatty acid oxidation disorders, including Carnitine uptake defect (CUD), Medium-chain acyl-CoA dehydrogenase deficiency (MCAD), Long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD), Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD), and Trifunctional protein deficiency (TFP). Congenital hypothyroidism (CH),
- Congenital adrenal hyperplasia (CAH),
- Cystic fibrosis (CF),
- Hemoglobin disorders, including Sickle cell anemia (HbSS), Hemoglobin SC disease (HbSC), and Hemoglobin S/β-thalassemia (HbS/βth
- Galactosemia (GALT)
- Biotinidase deficiency (BIOT)
Pharmacogenetic Testing
Prenatal Testing Offered
Prenatal testing will be covered for medically necessary non-invasive prenatal testing for fetal aneuploidy (trisomy 18, 13, and 21) and prenatal testing for microdeletions.
Whole Exome Sequencing
Other Tests Covered
- Propionic acidemia
- Methylmalonic acidemia (methylmalonyl-CoA mutase)
Other Information
- Telemedicine is the use of interactive audio-video equipment to link practitioners and members located at different sites. The Montana Healthcare Programs Program reimburses providers for medically necessary telemedicine services furnished to eligible members.
- Children’s Special Health Care Services (CSHCS) will help pay for genetic testing for children:
- https://dphhs.mt.gov/publichealth/cshs/GeneticFinancialAssistance
Resources
- BRCA Related Cancer Prior Authorization Criteria
- https://medicaidprovider.mt.gov/priorauthorization#260626763-brca-related-cancer
- Children’s Mental Health Bureau Medicaid Services Provider Manual https://dphhs.mt.gov/Portals/85/dsd/documents/CMB/providermanuals/CMHBMedicaidServicesProviderManualjuly2018.pdf
- DME Provider Manual
- https://medicaidprovider.mt.gov/manuals/durablemedicalequipmentprostheticsorthoticsandmedicalsuppliesmanual
- Montana Healthcare Programs notice: Fetal Chromosomal Aneuploidy Testing
- https://medicaidprovider.mt.gov/Portals/68/docs/providernotices/2018/provnoticefetalchromosomalaneuploitytesting01302018.pdf
- https://dphhs.mt.gov/ecfsd/cshs/NewbornScreeningPrograms/metabolicscreening/metabolicscreeninginformation
- Genetic Testing
- https://dphhs.mt.gov/ecfsd/cshs/geneticfinancialassistance (https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/heritable disorders/rusp/rusp-uniform-screening-panel.pdf)
Newborn Screening Reimbursement

Disclaimer: The information contained in the database has been obtained from sources believed to be reliable but NCC has not attempted to validate or confirm the information. The database may be updated periodically. However, the accuracy and completeness of the information contained in the database cannot be, and is not, guaranteed. NCC makes no warranty of the accuracy, completeness or timeliness of this information, and shall not be liable for any decision made in reliance on this information. It is the user’s responsibility to verify this information by contacting the state Medicaid agency directly.
The database contains links to third-party websites. These links are provided solely as a convenience to users and not as a guarantee, warrantee, or recommendation by NCC of the content on such third-party websites or as an indication of any affiliation, sponsorship or endorsement of such third party websites. NCC is not responsible for the content of linked third-party sites and does not make any representations regarding the privacy practices of, or the content or accuracy of materials on, such third-party websites. If you decide to access linked third-party websites, you do so at your own risk. Your use of third-party websites is subject to the terms of use for such sites.